BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24628621)

  • 1. Establishing HbA1c -mean blood glucose formulae for patients on continuous ambulatory peritoneal dialysis.
    Zhao C; Luo Q; He F; Peng F; Xia X; Huang F; Yu X
    Diabet Med; 2014 Jul; 31(7):813-20. PubMed ID: 24628621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
    Oei E; Samad N; Visser A; Chowdhury TA; Fan SL
    Diabet Med; 2016 Sep; 33(9):e17-20. PubMed ID: 26470840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Glycated Hemoglobin and Albumin-Corrected Glycated Serum Protein on Mortality in Diabetic Patients Receiving Continuous Peritoneal Dialysis.
    Peng F; Xia X; He F; Li Z; Huang F; Yu X
    Perit Dial Int; 2015; 35(5):566-75. PubMed ID: 25395497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis.
    Wu MS; Yu CC; Wu CH; Haung JY; Leu ML; Huang CC
    Perit Dial Int; 1999; 19 Suppl 2():S179-83. PubMed ID: 10406515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.
    Meyer L; Chantrel F; Imhoff O; Sissoko A; Serb L; Dorey F; Fleury D; Smagala A; Kepenekian L; Krummel T; Le Floch JP; Kessler L
    Diabet Med; 2013 Nov; 30(11):1388-9. PubMed ID: 23909880
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood glucose and cholesterol control improved by continuous ambulatory peritoneal dialysis in patients with end-stage renal disease and diabetes mellitus.
    Wikdahl AM; Granbom L; Sörensen JG; Stegmayr BG
    Perit Dial Int; 1993; 13 Suppl 2():S239-41. PubMed ID: 8399577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis.
    Lamb E; Cattell WR; Dawnay A
    Clin Sci (Lond); 1993 Jun; 84(6):619-26. PubMed ID: 8334808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin A1c in patients on peritoneal dialysis: how should we interpret it?
    Coelho S; Rodrigues A
    Ther Apher Dial; 2014 Oct; 18(5):375-82. PubMed ID: 24571450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison Study of Glucose Fluctuation During Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis.
    Okada E; Oishi D; Sakurada T; Yasuda T; Shibagaki Y
    Adv Perit Dial; 2015; 31():34-7. PubMed ID: 26714386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical characteristics of type 2 diabetic patients on continuous ambulatory peritoneal dialysis: relationships with insulin requirement.
    Wong TY; Chan JC; Szeto CC; Leung CB; Li PK
    Am J Kidney Dis; 1999 Sep; 34(3):514-20. PubMed ID: 10469863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Continuous Glucose Monitoring in Patients with Diabetes Mellitus on Peritoneal Dialysis: Correlation with Glycated Hemoglobin and Detection of High Incidence of Unaware Hypoglycemia.
    Qayyum A; Chowdhury TA; Oei EL; Fan SL
    Blood Purif; 2016; 41(1-3):18-24. PubMed ID: 26960210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
    Bomholt T; Feldt-Rasmussen B; Butt R; Borg R; Sarwary MH; Elung-Jensen T; Almdal T; Knop FK; Nørgaard K; Ranjan AG; Larsson A; Rix M; Hornum M
    Nephron; 2022; 146(2):146-152. PubMed ID: 34731864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis.
    Yu CC; Wu MS; Wu CH; Yang CW; Huang JY; Hong JJ; Fan Chiang CY; Leu ML; Huang CC
    Perit Dial Int; 1997; 17(3):262-8. PubMed ID: 9237287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemoglobin A1c in patients under periodic hemodialysis or continuous ambulatory peritoneal dialysis].
    Blumberg A; Marti HR
    Schweiz Med Wochenschr; 1986 Feb; 116(7):208-11. PubMed ID: 3952477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating HbA
    Law GR; Gilthorpe MS; Secher AL; Temple R; Bilous R; Mathiesen ER; Murphy HR; Scott EM
    Diabetologia; 2017 Apr; 60(4):618-624. PubMed ID: 28105519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric estimated average glucose in children with Type 1 diabetes.
    O'Riordan SM; Danne T; Hanas R; Peters CJ; Hindmarsh P
    Diabet Med; 2014 Jan; 31(1):36-9. PubMed ID: 23869869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.